Daniel A Barocas

Author PubWeight™ 60.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter? J Urol 2012 3.30
2 Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol 2011 2.51
3 Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. J Urol 2010 2.39
4 Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer. J Urol 2010 2.03
5 Recovery of urinary function after radical prostatectomy: identification of trajectory cluster groups. J Urol 2012 1.98
6 Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol 2012 1.85
7 National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. J Urol 2012 1.84
8 Volume outcomes of cystectomy--is it the surgeon or the setting? J Urol 2012 1.77
9 Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. Eur Urol 2007 1.76
10 Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer. J Urol 2011 1.72
11 Comparison of transfusion requirements between open and robotic-assisted laparoscopic radical prostatectomy. BJU Int 2010 1.66
12 Smaller prostate size predicts high grade prostate cancer at final pathology. J Urol 2010 1.62
13 Psychometric characteristics of a condition-specific, health-related quality-of-life survey: the FACT-Vanderbilt Cystectomy Index. Urology 2012 1.56
14 Impact of positive apical surgical margins on likelihood of biochemical recurrence after radical prostatectomy. J Urol 2009 1.55
15 Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients. Urology 2012 1.53
16 Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. J Urol 2010 1.50
17 Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy. BJU Int 2007 1.50
18 Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes. Cancer 2009 1.41
19 The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer. Urol Oncol 2011 1.01
20 Obesity, body composition, and prostate cancer. BMC Cancer 2012 1.00
21 Successful control of schistosomiasis and the changing epidemiology of bladder cancer in Egypt. BJU Int 2010 1.00
22 Prostate Cancer Early Detection, Version 2.2015. J Natl Compr Canc Netw 2015 0.98
23 The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial update. BJU Int 2015 0.97
24 The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer. Cancer Causes Control 2010 0.97
25 Gender, race, and variation in the evaluation of microscopic hematuria among Medicare beneficiaries. J Gen Intern Med 2014 0.96
26 ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma. BJU Int 2012 0.96
27 Centralization of radical prostatectomy in the United States. J Urol 2012 0.95
28 Immediate surgical outcomes for radical prostatectomy in the University HealthSystem Consortium Clinical Data Base: the impact of hospital case volume, hospital size and geographical region on 48,000 patients. BJU Int 2009 0.95
29 Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy. J Urol 2011 0.92
30 Gleason 6 Prostate Cancer: Translating Biology into Population Health. J Urol 2015 0.91
31 Anatomic basis for lymph node counts as measure of lymph node dissection extent: a cadaveric study. Urology 2013 0.90
32 Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience. J Urol 2012 0.89
33 Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small renal cortical tumours treated electively. BJU Int 2011 0.89
34 Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate size. Cancer Lett 2012 0.88
35 Determining factors for hospital discharge status after radical cystectomy in a large contemporary cohort. J Urol 2010 0.86
36 Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment. Cancer 2014 0.86
37 Impact of Adherence to Quality Measures for Localized Prostate Cancer on Patient-reported Health-related Quality of Life Outcomes, Patient Satisfaction, and Treatment-related Complications. Med Care 2016 0.84
38 Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy. J Urol 2009 0.83
39 Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies. Urology 2005 0.83
40 Comparative analysis of whole mount processing and systematic sampling of radical prostatectomy specimens: pathological outcomes and risk of biochemical recurrence. J Urol 2010 0.80
41 Knowledge of the harms of tobacco use among patients with bladder cancer. Cancer 2014 0.80
42 Effect of a large prostate gland on open and robotically assisted laparoscopic radical prostatectomy. BJU Int 2008 0.80
43 Tumor volume as a predictor of adverse pathologic features and biochemical recurrence (BCR) in radical prostatectomy specimens: a tale of two methods. World J Urol 2010 0.79
44 Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer. BJU Int 2009 0.78
45 Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy. BJU Int 2014 0.78
46 Radical nephrectomy surgical outcomes in the University HealthSystem Consortium Data Base: Impact of hospital case volume, hospital size, and geographic location on 40,000 patients. Cancer 2009 0.77
47 Editorial comment. J Urol 2012 0.75
48 Editorial comment. J Urol 2011 0.75
49 Editorial comment. J Urol 2010 0.75
50 Re: A multi-institution, minimally invasive urological oncology fellowship: a critical assessment of the clinical training and academic benefits. J. A. Brown and R. W. Lewis, J Urol 2006; 176: 2619-2623. J Urol 2007 0.75
51 Delivering high-quality care to prostate cancer survivors. Cancer 2013 0.75
52 Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer. J Urol 2008 0.75
53 Short term complications from transurethral resection of bladder tumor. Can J Urol 2016 0.75
54 The influence of provider characteristics and market forces on response to financial incentives. Am J Manag Care 2017 0.75
55 Improving quality through clinical registries in urology. Curr Opin Urol 2017 0.75
56 Outcomes session. Urol Oncol 2012 0.75
57 A urologic oncology roundtable discussion: the role of disease monitoring in treatment decision-making for patients with metastatic castration-resistant prostate cancer. Hosp Pract (1995) 2013 0.75